These findings highlight the relevance of subcellular-scale modeling. The proposed Microdosimetric Model, grounded on experimentally derived microdosimetric corrections, provides a robust framework to improve both the accuracy and the personalization of BNCT treatment planning.
Marcaccio et al. (Thu,) studied this question.